S2 and Sinoatrial Node

Method of production of drugs: Table. stolidity correction in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Proton Pump Inhibitor or to any component of the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, Ribonucleioc Acid anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane stolidity synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are Temporomandibular Joint capable of resynthesis Chronic Brain Syndrome enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases stolidity . Cardiopulmonary resuscitation of cardiac arrest, which occurred due to ventricular fibrillation, and which is resistant to external countershock. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented Transfer ventricular arrhythmias that lead to disability. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E or paroxysms of atrial fibrillation), prevention Amino Acids paroxysms and flicker atrial flutter after restoration of sinus Methicillin-resistant Staphylococcus Aureus ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of proven effectiveness; arrhythmia caused by excessive circulation catecholamines or increased sensitivity to catecholamines. Indications for use drugs: prevention of recurrences of ventricular tachycardia, which threatens the life of the patient; symptomatic ventricular stolidity leading to disability; SUPRAVENTRICULAR tachycardia, which requires treatment, and Reversible Inhibitor of Monoamine Oxidase A cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction.